Emerging Markets

The Ultimate Analysis of Pharmaceutical Markets in China and India

Decision Resources is the FIRST and ONLY company to offer a syndicated report series for high-growth emerging markets with comprehensive disease-specific analysis. With these reports, clients are able to:

• More accurately assess commercial opportunity for Western brands in China and India 
• Understand the physician treatment patterns and drivers of choice in key urban areas based on primary research 
• Gain a clear perspective from a 5-year, drug-level market forecast, which is broken out by multinational sales versus Chinese/India-based companies

Each report assesses the commercial opportunity in the pharmaceutical market for a disease based on population demographics, economic development, disease epidemiology and changing physicians’ practices. Key elements of each report include:

• Accurate sizing of the patient population with access to Western medicine
• Projections for future patient populations based on trends in lifestyle, urbanization and economic status
• Current treatment patterns and drivers of choice
• Physician-defined unmet needs in diagnosing and treating the disease
• Disease-specific pricing and reimbursement environment
• Key drivers of market growth

Methodology for Generating Chinese Epidemiology Estimates

Our most recent Emerging Markets reports:

Issues in Diagnosis and Treatment of Psychiatric Disorders in China

Breast Cancer in India

Alzheimer's Disease in China

Major Depression in China

Type 2 Diabetes in India

View 2008 Emerging Markets report titles

Download our Emerging Markets-China brochure